Oxford Vaccine Group begins human trial of Nipah virus vaccine
Thursday, 11 January 2024
Oxford Vaccine Group is leading the trail for the Nipah virus vaccine, and the group is backend with the support of CEPI in terms of funds.
|
||||
You Might Like |
||||
